[1]
|
World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. Geneva: WHO; 2022 Oct. https://www.who.int/publications/i/item/9789240060241. |
[2]
|
Bing J, Du H, Guo PH, Hu TR, Xiao M, Lu S, et al. Candida auris-associated hospitalizations and outbreaks, China, 2018-2023. Emerg Microbes Infect 2024;13(1):2302843.CrossRef
|
[3]
|
Fan X, Dai RC, Zhang S, Geng YY, Kang M, Guo DW, et al. Tandem gene duplications contributed to high-level azole resistance in a rapidly expanding Candida tropicalis population. Nat Commun 2023;14(1):8369.CrossRef
|
[4]
|
Hong H, Ximing Y, Jinghan M, Al-Danakh A, Shujuan P, Ying L, et al. Candida auris infection; diagnosis, and resistance mechanism using high-throughput sequencing technology: a case report and literature review. Front Cell Infect Microbiol 2023;13:1211626.CrossRef
|
[5]
|
Chen XF, Zhang H, Liu LL, Guo LN, Liu WJ, Liu YL, et al. Genome-wide analysis of in vivo-evolved Candida auris reveals multidrug-resistance mechanisms. Mycopathologia 2024;189(3):35.CrossRef
|
[6]
|
Spruijtenburg B, Ahmad S, Asadzadeh M, Alfouzan W, Al-Obaid I, Mokaddas E, et al. Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates. Mycoses 2023;66(12):1079 − 86.CrossRef
|
[7]
|
Gifford H, Rhodes J, Farrer RA. The diverse genomes of Candida auris. Lancet Microbe 2024;5(9):100903.CrossRef
|
[8]
|
Mishra SK, Yasir M, Willcox M. Candida auris: an emerging antimicrobial-resistant organism with the highest level of concern. Lancet Microbe 2023;4(7):e482 − 3.CrossRef
|
[9]
|
Wasylyshyn A, Stoneman EK. Management of Candida auris. JAMA 2024;331(7):611 − 2.CrossRef
|
[10]
|
Suphavilai C, Ko KKK, Lim KM, Tan MG, Boonsimma P, Chu JJK, et al. Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study. Lancet Microbe 2024;5(9):100878.CrossRef
|